The invention relates novel biomarkers for prediabetes and diabetes. Specifically, use of a set of probes with specific binding affinities to prediabetes and diabetes protein markers for screening prediabetes and diabetes for care and/or treatment is disclosed. A diagnostic kit device/apparatus comprising a set of probes is disclosed. A method for detecting and identifying prediabetes and/or diabetes in a subject in need thereof is also disclosed. The subject in need thereof identified as having prediabetes or diabetes is subject to a care and/or a treatment regime for the prediabetes or diabetes. Also disclosed is a method for identifying prediabetes and/or diabetes protein markers.
- A combination of iTRAQ/MS techniques, IPA, and ROC curve analysis leads to identification of novel (pre)diabetes
- markers.
- A combinational use of MLL4, LAMA2 and PLXDC2 can predict over 70% of patients with new-onset T2D.
- The sensitivity and specificity of the T2D prediction increases with a combination of the 3 biomarkers with more other
- (pre)diabetic markers.

FIG 1. Diagnosis efficacy was analyzed using ROC curve
14A-1070815
- Method and apparatus of detecting (per)diabetes in patient’s serum.
- Method and apparatus of detecting (per)diabetes using our novel markers with other (pre)diabetes
- markers
Wen-Chin Yang
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A method of detecting (pre)diabetes using protein markers